Explore more publications!

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on September 11, 2025

Faclon Labs Launches Revolutionary AI-Powered Manufacturing Intelligence Platform
PRP Labs Announces Centrifuge Trade-In Program with Free Centrifuge Upgrade Opportunity for Clinics
EIN Presswire Unveils First Case Study on Using Press Releases to Increase AI Search Visibility and Media Coverage
Dr. Peter Loisides Wins Best of Los Angeles Award — 'Best Urologist - 2025'
UCLA Undergraduate Students Win Top Honors for Lyme Disease Detection Research
OnsiteGene Unveils myNAT™ PCR Platform for Faster, Accurate Multiplex Testing
Dr. Steve Nandkeshwar Joins Esteemed Human Touch® Wellness Council
Gracious Wellsprings Opens Third Los Angeles Recovery Home, Expanding Addiction and Mental Health Support Access
Scotwork North America Hosts Free Webinar 'Ready For Renewals?'
MLOps Crew Strengthens U.S. Presence with Advanced AI & MLOps Solutions
Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
Roivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma List
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
Kestra Medical Technologies Reports First Quarter Fiscal 2026 Financial Results
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Recludix Pharma to Present at the Stifel 2025 Virtual Immunology and Inflammation Forum

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions